When therapeutic drugs lead to diabetes Bruno FèveAndré J. Scheen Review 04 March 2022 Pages: 751 - 762
Epigenome-wide association study of incident type 2 diabetes: a meta-analysis of five prospective European cohorts Eliza FraszczykAnnemieke M. W. SpijkermanHarold Snieder Article Open access 15 February 2022 Pages: 763 - 776
Sedentary behaviour and physical activity are associated with biomarkers of endothelial dysfunction and low-grade inflammation—relevance for (pre)diabetes: The Maastricht Study Evelien J. VandercappellenAnnemarie KosterCoen D. A. Stehouwer Article Open access 04 February 2022 Pages: 777 - 789
Separating the direct effects of traits on atherosclerotic cardiovascular disease from those mediated by type 2 diabetes Venexia M. WalkerMarijana VujkovicScott M. Damrauer Article Open access 07 February 2022 Pages: 790 - 799
Familial aggregation and shared genetic loading for major psychiatric disorders and type 2 diabetes Mei-Hsin SuYing-Hsiu ShihShi-Heng Wang Article 23 February 2022 Pages: 800 - 810
Spatial and transcriptional heterogeneity of pancreatic beta cell neogenesis revealed by a time-resolved reporter system Shugo SasakiMichelle Y. Y. LeeTakeshi Miyatsuka Article 03 March 2022 Pages: 811 - 828
Proinflammatory cytokines induce rapid, NO-independent apoptosis, expression of chemotactic mediators and interleukin-32 secretion in human pluripotent stem cell-derived beta cells Rabea DettmerIsabell NiwolikOrtwin Naujok Article Open access 05 February 2022 Pages: 829 - 843
Early DNA methylation changes in children developing beta cell autoimmunity at a young age Inna StarskaiaEssi LaajalaRiitta Lahesmaa Article Open access 10 February 2022 Pages: 844 - 860
Prediabetes blunts DPP4 genetic control of postprandial glycaemia and insulin secretion Rita S. PatarrãoNádia DuarteCarlos Penha-Gonçalves Article Open access 22 February 2022 Pages: 861 - 871
Urinary albumin/creatinine ratio tertiles predict risk of diabetic retinopathy progression: a natural history study from the Adolescent Cardio-Renal Intervention Trial (AdDIT) observational cohort Paul Z. Benitez-AguirreM. Loredana Marcovecchioon behalf of the Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT) Short Communication Open access 19 February 2022 Pages: 872 - 878
Endothelial glycocalyx is damaged in diabetic cardiomyopathy: angiopoietin 1 restores glycocalyx and improves diastolic function in mice Yan QiuStanley BuffongeSimon C. Satchell Article Open access 25 February 2022 Pages: 879 - 894
Reversibility of brain glucose kinetics in type 2 diabetes mellitus Elizabeth Sanchez-RangelFelona GunawanJanice Jin Hwang Article Open access 05 March 2022 Pages: 895 - 905
Ertugliflozin, renoprotection and potential confounding by muscle wasting Dion GroothofAdrian PostStephan J. L. Bakker Letter 23 December 2021 Pages: 906 - 907
Ertugliflozin, renoprotection and potential confounding by muscle wasting. Reply to Groothof D, Post A, Gans ROB et al [letter] David Z. I. CherneyBernard Charbonnelon behalf of the VERTIS CV Investigators Letter Open access 03 March 2022 Pages: 908 - 911
Correction to: A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY Jarno L. T. KettunenElina RantalaTiinamaija Tuomi Correction 03 March 2022 Pages: 912 - 912